DE602005012317D1 - Verwendung von acetyl-l-carinitin zur behandlung des fibromyalgischen syndroms - Google Patents
Verwendung von acetyl-l-carinitin zur behandlung des fibromyalgischen syndromsInfo
- Publication number
- DE602005012317D1 DE602005012317D1 DE602005012317T DE602005012317T DE602005012317D1 DE 602005012317 D1 DE602005012317 D1 DE 602005012317D1 DE 602005012317 T DE602005012317 T DE 602005012317T DE 602005012317 T DE602005012317 T DE 602005012317T DE 602005012317 D1 DE602005012317 D1 DE 602005012317D1
- Authority
- DE
- Germany
- Prior art keywords
- acetyl
- treatment
- syndrome
- fibromyalgian
- carinitine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000606A ITRM20040606A1 (it) | 2004-12-13 | 2004-12-13 | Uso della acetil l-carnitina per il trattamento della sindrome fibromialgica. |
| PCT/EP2005/012054 WO2006063639A1 (en) | 2004-12-13 | 2005-11-10 | Use of acetyl l-carnitine for the treatment of fibromyalgic syndrome |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602005012317D1 true DE602005012317D1 (de) | 2009-02-26 |
Family
ID=35708966
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602005012317T Expired - Lifetime DE602005012317D1 (de) | 2004-12-13 | 2005-11-10 | Verwendung von acetyl-l-carinitin zur behandlung des fibromyalgischen syndroms |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US8013016B2 (enExample) |
| EP (1) | EP1824472B1 (enExample) |
| JP (1) | JP5057990B2 (enExample) |
| KR (1) | KR101240182B1 (enExample) |
| AT (1) | ATE419847T1 (enExample) |
| CA (1) | CA2585560C (enExample) |
| CY (1) | CY1110576T1 (enExample) |
| DE (1) | DE602005012317D1 (enExample) |
| DK (1) | DK1824472T3 (enExample) |
| ES (1) | ES2320788T3 (enExample) |
| IT (1) | ITRM20040606A1 (enExample) |
| MX (1) | MX2007006954A (enExample) |
| PL (1) | PL1824472T3 (enExample) |
| PT (1) | PT1824472E (enExample) |
| SI (1) | SI1824472T1 (enExample) |
| WO (1) | WO2006063639A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2840363A1 (en) * | 2011-06-24 | 2012-12-27 | K-Pax Pharmaceuticals, Inc. | Compositions comprising a central nervous system stimulant and select micronutrients useful in the treatment of chronic fatigue |
| ES2962933T3 (es) | 2020-12-14 | 2024-03-21 | Ims Gear Se & Co Kgaa | Procedimiento para la corrección de una señal de medición dependiente del tiempo de una unidad de motor-engranaje, así como procedimiento para detectar desgaste y/o un deterioro de la misma mediante este procedimiento de corrección |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1150396B (it) * | 1982-12-09 | 1986-12-10 | Sigma Tau Ind Farmaceuti | Impiego di alcanoil l-carnitine per il trattamento terapeutico di miopa tie e distrofie muscolari |
| EP0681839A3 (en) * | 1994-05-12 | 1997-11-12 | Hirohiko Kuratsune | A pharmaceutical preparation comprising an acylcarnitine |
| US6025368A (en) * | 1997-02-25 | 2000-02-15 | Celtrix Pharmaceuticals, Inc. | Method for treating the symptoms of chronic stress-related disorders using IGF |
| US5935949A (en) * | 1998-03-20 | 1999-08-10 | Trustees Of Dartmouth College | Use of androgen therapy in fibromyalgia and chronic fatigue syndrome |
| US6803387B1 (en) | 1999-03-19 | 2004-10-12 | Abbott Gmbh & Co. Kg | Treatment of neuropathic pain or fibromyalgia |
| ITRM20010293A1 (it) | 2001-05-29 | 2002-11-29 | Sigma Tau Ind Farmaceuti | Uso della acetil-l-carnetina per la preparazione di un medicamento per la prevenzione del dolore. |
| KR101027570B1 (ko) * | 2002-05-03 | 2011-04-06 | 이스라엘 인스티튜트 포 바이올로지컬 리서치 | 중추 및 말초 신경계 장애의 치료를 위한 방법 및 조성물, 및 그에 유용한 신규 화합물 |
-
2004
- 2004-12-13 IT IT000606A patent/ITRM20040606A1/it unknown
-
2005
- 2005-11-10 SI SI200530579T patent/SI1824472T1/sl unknown
- 2005-11-10 US US11/719,447 patent/US8013016B2/en not_active Expired - Fee Related
- 2005-11-10 CA CA2585560A patent/CA2585560C/en not_active Expired - Fee Related
- 2005-11-10 JP JP2007544754A patent/JP5057990B2/ja not_active Expired - Fee Related
- 2005-11-10 AT AT05807584T patent/ATE419847T1/de active
- 2005-11-10 PL PL05807584T patent/PL1824472T3/pl unknown
- 2005-11-10 MX MX2007006954A patent/MX2007006954A/es active IP Right Grant
- 2005-11-10 WO PCT/EP2005/012054 patent/WO2006063639A1/en not_active Ceased
- 2005-11-10 EP EP05807584A patent/EP1824472B1/en not_active Expired - Lifetime
- 2005-11-10 DE DE602005012317T patent/DE602005012317D1/de not_active Expired - Lifetime
- 2005-11-10 PT PT05807584T patent/PT1824472E/pt unknown
- 2005-11-10 DK DK05807584T patent/DK1824472T3/da active
- 2005-11-10 KR KR1020077015272A patent/KR101240182B1/ko not_active Expired - Fee Related
- 2005-11-10 ES ES05807584T patent/ES2320788T3/es not_active Expired - Lifetime
-
2009
- 2009-03-31 CY CY20091100383T patent/CY1110576T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1824472B1 (en) | 2009-01-07 |
| ITRM20040606A1 (it) | 2005-03-13 |
| JP5057990B2 (ja) | 2012-10-24 |
| ATE419847T1 (de) | 2009-01-15 |
| US20090076146A1 (en) | 2009-03-19 |
| KR101240182B1 (ko) | 2013-03-07 |
| KR20070091317A (ko) | 2007-09-10 |
| CY1110576T1 (el) | 2015-04-29 |
| CA2585560C (en) | 2013-01-08 |
| PL1824472T3 (pl) | 2009-05-29 |
| SI1824472T1 (sl) | 2009-04-30 |
| ES2320788T3 (es) | 2009-05-28 |
| MX2007006954A (es) | 2007-08-02 |
| EP1824472A1 (en) | 2007-08-29 |
| CA2585560A1 (en) | 2006-06-22 |
| WO2006063639A1 (en) | 2006-06-22 |
| DK1824472T3 (da) | 2009-03-30 |
| JP2008534433A (ja) | 2008-08-28 |
| PT1824472E (pt) | 2009-03-31 |
| US8013016B2 (en) | 2011-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60109044D1 (de) | Arzneimittel zur behandlung der mucositis, stomatitis und des behcetschen syndroms | |
| ATE390407T1 (de) | Phenethanolamin-derivate zur behandlung von atemwegserkrankungen | |
| DE502007002101D1 (de) | Arzneimittel mit Dobesilat-Calcium zur Behandlung und Prophylaxe von Sehnenerkrankungen | |
| DE59914712D1 (de) | Verwendung von inhibitoren des kqt1-kanals zur herstellung eines medikaments zur behandlung von krankheiten, die durch helminthen und ektoparasiten hervorgerufen werden | |
| CY1109051T1 (el) | Χρηση καρνιτινων για την προληψη και/ή θεραπεια διαταραχων που προκαλουνται απο την ανδροπαυση | |
| ATE311866T1 (de) | Verwendung von r-arylpropionsäuren zur herstellung von arzneimitteln zur behandlung von erkrankungen rheumatischer natur | |
| ATE319473T1 (de) | Melagatran zur behandlung von entzündungen | |
| DE602005012317D1 (de) | Verwendung von acetyl-l-carinitin zur behandlung des fibromyalgischen syndroms | |
| DE60200160D1 (de) | Verwendung von Cilobradine oder pharmazeutisch akzeptablen Salze zur Behandlung oder Prävention von Herzversagen | |
| DE60319241D1 (de) | Analoga zur behandlung von thalassämie | |
| ATE281172T1 (de) | Verwendung von cdp-choline zur behandlung des alkoholentzugsyndroms | |
| CY1107037T1 (el) | Χρηση ακετυλ l-καρνιτινης για την παρασκευη ενος φαρμακου για την προληπτικη αγωγη του μετεγχειρητικου πονου | |
| SI1492521T1 (sl) | Kombinirana uporaba l-karnitina, acetil l-karnitina in propil l-karnitina za zdravljenje oligoastenoteratospermije | |
| CY1112144T1 (el) | Ενωση χρησιμη για την προληψη και θεραπεια της υπερτροφιας αριστερης κοιλιας σε ασθενεις υπο αιμοκαθαρση | |
| DE60305018D1 (de) | Citalopram zur behandlung von bluthochdruck | |
| JO2666B1 (en) | Use of agomelatine for medications to treat bilateral mental disorders | |
| ATE345124T1 (de) | Verwendung von l-acetylcarnitin zur herstellung eines medikaments zur behandlung von anhedonia | |
| DE60206391D1 (de) | Verwendung von thiazolderivaten zur herstellung eines medikaments zur behandlung von chronischen obstruktiven atemwegserkrankungen | |
| ATE330597T1 (de) | Verwendung von fibrate zur herstellung eines arzneimittel zur behandlung von kongestiven herzversagens | |
| ATE365038T1 (de) | ARZNEIMITTEL ZUR BEHANDLUNG DES ßSYSTEMIC INFLAMMATORY RESPONSE SYNDROMEß | |
| ATE353638T1 (de) | Verwendung von nf-kappa b hemmern zur behandlung von brustdrüsenentzündung | |
| ATE418977T1 (de) | Verwendung von phenylacetylderivaten zur herstellung eines arzneimittels zur behandlung der von-hippel-lindau-erkrankung | |
| ITRM20020181A0 (it) | Medicamento utile per il trattamento della fatica in pazienti affettida sclerosi multipla. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |